A Phase II Trial Evaluating the Safety and the Efficacy of Trastuzumab in Relapsed/Refractory HER2 Positive B-Acute Lymphoblastic Leukemia Patients.
Phase of Trial: Phase II
Latest Information Update: 05 Oct 2013
At a glance
- Drugs Trastuzumab (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 10 Dec 2011 Results, for the first time, have been reported at the 53rd Annual Meeting and Exposition of the American Society of Hematology.
- 18 Aug 2008 New trial record.